bf/NASDAQ:SGEN_icon.png

NASDAQ:SGEN

Seagen Inc.

  • Stock

228.74

−0.07%

−0.16

USD last updated 11/08 02:03:55

Last Close

228.90

13/12 21:00

Market Cap

43.15B

Beta: 0.53

Volume Today

19.39M

Avg: 1.64M

PE Ratio

−57.36

PFCF: −61.54

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothel...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2-11232015-02-102017-02-092019-02-072021-02-112023-02-15

    Revenue (Estimate*)

    500M1B1.50B2015-02-102017-02-092019-02-072021-02-112023-02-15

    *Estimate based on analyst consensus